...Sucampo (NASDAQ:SCMP)/ Takeda (Tokyo:4502) Amitiza lubiprostone (SPI-0211) Constipation-predominant irritable bowel syndrome (IBS) PDUFA date 4/29/08 Symbollon...

...Symbollon will acquire 64% of Xi’an for $1.5 million in stock. Symbollon also will receive an...
...purchase the rest of Xi’an for cash. The acquisition is expected to close next month. Symbollon...
...cash flow from Xi’an’s 2008 revenues and access to the Chinese market for Symbollon’s products. Symbollon’s...

...NDA Apr 08 (data); 2H08 (NDA) Somaxon (NASDAQ:SOMX) Silenor doxepin (SO-101) Insomnia Submit NDA 1Q08 Symbollon...

...U.S. Phase III trial of IoGen to treat moderate to severe pain associated with FBD. Symbollon...

...Insomnia Submit NDA 3Q07 Sonus (SNUS)/Schering (FSE:SCH; SHR) Tocosol paclitaxel Breast cancer Submit NDA YE07 Symbollon...

...The deal is expected to close Sept. 30. Gardent Pharmaceuticals Inc. (GRDP), New York, N.Y. Symbollon Pharmaceuticals Inc....

...commercialization expenses and the companies will share profits. Bioaccelerate Holdings Inc. (BACL), New York, N.Y. Symbollon Pharmaceuticals Inc....

...to conservative treatment. Patients will receive 6 mg IoGen or placebo daily for 6 months. Symbollon...